PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bradbury, PA
  • Jang, R
  • Isogai, P
  • Ng, R
  • Mittmann, N
  • Evans, William
  • Shepherd, FA
  • Leighl, NB

publication date

  • May 2008